Immune checkpoint inhibitor toxicity and associated outcomes in a geriatric population.

被引:0
|
作者
Polewski, Peter James
Hayashi-Tanner, Yacki
Gaddam, Mamatha
Fisher, Nancy R.
Kovacs, Attila J.
Marinier, David E.
机构
[1] Gundersen Hlth Syst, La Crosse, WI USA
[2] Gundersen H, La Crosse, WI USA
[3] Gunderson Med Fdn, La Crosse, WI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e24014
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer
    Hayashi-Tanner, Yacki
    Polewski, Peter J.
    Gaddam, Mamatha
    Fisher, Nancy R.
    Kovacs, Attila J.
    Marinier, David E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) : 1011 - 1016
  • [2] Is a clinical biomarker predictive of outcomes with immune checkpoint inhibitor (ICI) therapy in a phase I patient population.
    Vaishampayan, Ulka N.
    Kim, Seongho
    Karwa, Jaswinder
    Mamdani, Hirva
    Lange, Lisa
    Harfoot, Danielle
    Jamison, Andrea
    Williams, Lindsay
    Wilson, Kelley
    Weise, Amy M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Immune Checkpoint Inhibitor Toxicity
    Palmieri, David J.
    Carlino, Matteo S.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [4] Immune Checkpoint Inhibitor Toxicity
    David J. Palmieri
    Matteo S. Carlino
    Current Oncology Reports, 2018, 20
  • [5] Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity
    Suresh, Karthik
    D'Alessio, Franco
    CRITICAL CARE MEDICINE, 2019, 47 (09) : E788 - E788
  • [6] Immune Checkpoint Inhibitor Toxicity in 2018
    Johnson, Douglas B.
    Chandra, Sunandana
    Sosman, Jeffrey A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (16): : 1702 - 1703
  • [7] Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy
    Mangan, Brendan L.
    McAlister, Renee K.
    Balko, Justin M.
    Johnson, Douglas B.
    Moslehi, Javid J.
    Gibson, Andrew
    Phillips, Elizabeth J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (09) : 1778 - 1789
  • [8] Opportunistic infection outcomes in patients receiving corticosteroids for immune checkpoint inhibitor toxicity
    Cook, Michael
    Atkins, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] Prevalence and Outcomes of Immune Checkpoint Inhibitor (ICI) Associated Colitis: A Population-Based Cohort Study
    Tunio, Nahel A.
    Desai, Aakash
    Dalal, Shaman
    Kurin, Michael
    Waghray, Nisheet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S157 - S157
  • [10] OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN MALIGNANCY-ASSOCIATED DERMATOMYOSITIS
    Fernandez, D. R.
    Thaler, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 559 - 559